Suppr超能文献

VLA - 6层粘连蛋白受体在乳腺癌侵袭中的作用。

A role of VLA-6 laminin receptor in invasion of breast carcinoma.

作者信息

Arihiro K, Inai K, Kurihara K, Takeda S, Khatun N, Kuroi K, Toge T

机构信息

Second Department of Pathology, Hiroshima University School of Medicine, Japan.

出版信息

Acta Pathol Jpn. 1993 Nov;43(11):662-9. doi: 10.1111/j.1440-1827.1993.tb02550.x.

Abstract

The integrin VLA-6 as a laminin receptor and laminin as a ligand for laminin receptor were detected immunohistochemically in normal, benign tumor and carcinoma tissues of the breast. Epithelial cells of both normal breast and benign tumor were in almost all cases strongly immunoreactive for VLA-6 in the plasma membrane. Carcinoma cells in 34 of 70 cases (49%) with an invasive component were not immunoreactive for VLA-6, and no carcinoma cells showed strong positivity. Although carcinoma cells in only four of 51 cases (8%) with intraductal components were negative for VLA-6, 37 cases (72%) showed weak expression of VLA-6 and 10 cases (20%) showed strong expression of VLA-6. A concordant expression of VLA-6 on carcinoma cells and laminin around carcinoma cell nests with an invasive component was observed, and VLA-6 expression in carcinoma cells was correlated to tubular formation in carcinoma cell nests as an indicator of differentiation. These findings suggest that loss of VLA-6 plays a role in the invasion of breast carcinoma, and that VLA-6 laminin receptor and laminin may contribute to tubular differentiation of breast carcinoma cells.

摘要

在乳腺的正常组织、良性肿瘤组织和癌组织中,采用免疫组织化学方法检测了整合素VLA - 6作为层粘连蛋白受体以及层粘连蛋白作为层粘连蛋白受体的配体的情况。正常乳腺和良性肿瘤的上皮细胞在几乎所有情况下,其质膜中的VLA - 6均呈强免疫反应性。70例具有浸润成分的病例中,34例(49%)的癌细胞对VLA - 6无免疫反应性,且没有癌细胞呈强阳性。在51例具有导管内成分的病例中,仅4例(8%)的癌细胞VLA - 6呈阴性,37例(72%)呈VLA - 6弱表达,10例(20%)呈VLA - 6强表达。观察到具有浸润成分的癌细胞巢周围癌细胞与层粘连蛋白上VLA - 6的表达一致,且癌细胞中VLA - 6的表达与癌细胞巢中作为分化指标的管状结构形成相关。这些发现表明,VLA - 6的缺失在乳腺癌的侵袭中起作用,并且VLA - 6层粘连蛋白受体和层粘连蛋白可能有助于乳腺癌细胞的管状分化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验